Form 8-K - Current report:
SEC Accession No. 0000950142-22-002314
Filing Date
2022-07-27
Accepted
2022-07-27 07:26:22
Documents
15
Period of Report
2022-07-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K eh220274048_8k.htm   iXBRL 8-K 32510
2 EXHIBIT 10.1 eh220274048_ex1001.htm EX-10.1 84100
3 EXHIBIT 10.2 eh220274048_ex1002.htm EX-10.2 93264
4 EXHIBIT 99.1 eh220274048_ex9901.htm EX-99.1 12552
  Complete submission text file 0000950142-22-002314.txt   449547

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE vtvt-20220725.xsd EX-101.SCH 2980
6 XBRL LABEL FILE vtvt-20220725_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE vtvt-20220725_pre.xml EX-101.PRE 22373
9 EXTRACTED XBRL INSTANCE DOCUMENT eh220274048_8k_htm.xml XML 3610
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

EIN.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37524 | Film No.: 221108843
SIC: 2834 Pharmaceutical Preparations